Dongjuan Chen
Papers
1
Total Citations
30
H-Index
1
About
Dongjuan Chen is a pioneering researcher in the field of microfluidics and single-cell analysis, with a particular focus on advancing cancer drug evaluation. Her most cited work, "A microfluidic digital single-cell assay for the evaluation of anticancer drugs" (2014), has garnered 30 citations, reflecting its foundational impact on high-throughput, precise drug screening technologies. Chen’s major contribution lies in developing innovative microfluidic platforms that enable the isolation and analysis of individual cells, allowing for unprecedented accuracy in assessing drug efficacy and resistance at the single-cell level. This approach addresses critical limitations of bulk assays, offering deeper insights into heterogeneous tumor responses. Her work bridges engineering and biomedicine, providing tools that enhance personalized cancer therapy development. Chen’s research has been recognized for its translational potential, influencing both academic studies and clinical applications. By enabling real-time, quantitative evaluation of anticancer agents, she has set a new standard for drug testing methodologies. Her achievements underscore a commitment to precision medicine, making her a key figure in microfluidics-based oncology research.
Research Focus
Key Achievements
Top Papers
- 1